Skip to main content

Table 3 Characteristics of the sample (N = 255)

From: Prevalence and correlates of healthy lifestyle behaviors among early cancer survivors

Variable

Variable

 

Age years (SD)

60.6 (10.7)

Type of cancer

 

Gender

 

 Breast, n (%)

150 (58.8)

 Female, n (%)

193 (70.7)

 Colon, n (%)

51 (20)

Marital status

 

 Other, n (%)a

54 (21.1)

 Living with partner, n (%)

217 (86.5)

Type of treatment

 

Educational level

 

 Surgery alone, n (%)

32 (12.6)

 Low, n (%)

137 (54.6)

 Surgery and chemotherapy, n (%)

55 (21.7)

 Medium, n (%)

47 (18.7)

 Surgery and radiotherapy, n (%)

46 (18.1)

 High, n (%)

67 (26.3)

 Surgery, chemo- & radiotherapy, n (%)

92 (36.2)

Employment status

 

 Other, n (%)

29 (11.4)

 Not working, n (%)

158 (64)

Participation in aftercare

 

Income level

 

 Yes, n (%)

134 (53)

 Below average, n (%)

51 (21.1)

Number of weeks after treatment, mean (SD)

26.5 (12.7)

 Average, n (%)

70 (28.9)

HADS, mean, (SD)

8.2 (6.7)

 Above average, n (%)

121 (50)

 HADS anxiety, mean (SD)

4.7 (3.9)

BMI, mean (SD)

26.7 (9.4)

 HADS depression, mean (SD)

3.5 (3.5)

 < 18,5: underweight, n (%)

1 (0.4)

MAC

 

 18,5-25: healthy weight, n (%)

113 (45.7)

 Positive adjustment, mean (SD)

51.1 (7.0)

 25-30: overweight, n (%)

95 (38.5)

 Negative adjustment, mean (SD)

29.6 (7.0)

 30-35: obesity, n (%)

25 (10.1)

IPQR, mean (SD)

32.5 (10.9)

 > 35: extreme obesity, n (%)

13 (5.3)

SPSIR

 

EORTC QLQ-C30

 

 Positive problem orientation, mean (SD)

2.4 (0.8)

 Global health status, mean (SD)

78.1 (16.5)

 Negative problem orientation, mean (SD)

1.1 (0.9)

 Physical functioning, mean (SD)

85 (15.3)

Alcohol Attitude, mean (SD)

2.2 (1.3)

 Role functioning, mean (SD)

79.4 (23.8)

 Social support, mean (SD)

2.2 (1.5)

 Emotional functioning, mean (SD)

80.1 (20.4)

 Self-efficacy, mean (SD)

3.6 (1.3)

 Cognitive functioning, mean (SD)

80.6 (22)

 Intention, mean (SD)

2.4 (1.5)

 Social functioning, mean (SD)

82.8 (21.4)

Physical Activity Attitude, mean (SD)

4.6 (0.5)

 Body Image, mean (SD)

82.3 (22.8)

 Social support, mean (SD)

3.6 (1.2)

 Fatigue, mean (SD)

27 (23.9)

 Self-efficacy, mean (SD)

3.5 (1.1)

 Nausea and Vomiting, mean (SD)

3.3 (10.3)

 Intention, mean (SD)

4.7 (0.7)

 Pain, mean (SD)

15.9 (22.6)

Nutrition Attitude, mean (SD)

4.1 (0.7)

 Dyspnea, mean (SD)

12 (21.9)

 Social support, mean (SD)

3.1 (1.3)

 Insomnia, mean (SD)

26.1 (28)

 Self-efficacy, mean (SD)

3 (0.9)

 Appetite loss, mean (SD)

6.2 (16.6)

 Intention vegetable consumption, mean (SD)

4.2 (1.0)

 Constipation, mean (SD)

8.2 (18.4)

 Intention fruit consumption, mean (SD)

4.0 (1.1)

 Diarrhea, mean (SD)

7.5 (20)

  

 Financial difficulties, mean (SD)

10.6 (22.5)

  
  1. Notes: n: numbers of participants; SD: standard deviation; BMI: Body Mass Index; EORTC: European Organisation for Research and Treatment of Cancer; QoL: Quality of Life; HADS: Hospital Anxiety and Depression Scale;MAC: Mental Adjustment to Cancer scale; IPQ: Illness Perception Questionnaire; SPSIR-R:S Short Social Problem Solving Inventory-Revised
  2. a other types of cancer were prostate (9 %); Non-Hodgkins’s lymphpma (5.9 %), ovarian (3.1 %); bladder (1.2 %); cervix (0.4 %); Hodgkins’s lymphpma (0.4 %)